Elizabeth A Grimm Selected Research

interleukin-20 receptor

2/2007	Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10.
5/2005	mda-7/IL24 kills pancreatic cancer cells by inhibition of the Wnt/PI3K signaling pathways: identification of IL-20 receptor-mediated bystander activity against pancreatic cancer.
12/2004	Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth A Grimm Research Topics

Disease

66	Melanoma (Melanoma, Malignant) 05/2022 - 02/2002
64	Neoplasms (Cancer) 05/2022 - 02/2002
6	Neoplasm Metastasis (Metastasis) 12/2020 - 02/2002
5	Inflammation (Inflammations) 01/2016 - 11/2011
4	Carcinogenesis 05/2016 - 04/2006
4	Lung Neoplasms (Lung Cancer) 01/2012 - 03/2004
3	Uveal melanoma 10/2019 - 01/2016
3	Disease Progression 01/2017 - 05/2004
3	Nevus (Nevi) 04/2010 - 05/2004
3	Breast Neoplasms (Breast Cancer) 02/2007 - 10/2002
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 05/2005
2	Hypoxia (Hypoxemia) 10/2016 - 08/2014
2	Renal Cell Carcinoma (Grawitz Tumor) 03/2009 - 06/2003
2	Hypothyroidism 08/2004 - 09/2003
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017
1	Wilms Tumor (Wilm's Tumor) 01/2017
1	Adenocarcinoma 10/2016
1	Chromosome Breakage 04/2016
1	Tuberous Sclerosis (Bourneville's Disease) 02/2014
1	Chronic Renal Insufficiency 01/2013

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2002
18	CytokinesIBA 01/2017 - 07/2002
15	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021 - 01/2003
13	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 10/2002
11	interleukin-24 (ST16)IBA 02/2011 - 02/2002
8	Interleukin-10 (Interleukin 10)IBA 01/2015 - 01/2004
5	Biological ProductsIBA 01/2022 - 09/2003
5	Nitric Oxide Synthase (NO Synthase)IBA 01/2017 - 10/2002
5	Messenger RNA (mRNA)IBA 01/2016 - 09/2005
5	InterleukinsIBA 11/2011 - 08/2003
4	Macrophage Migration-Inhibitory FactorsIBA 05/2022 - 11/2015
4	InterferonsIBA 01/2022 - 07/2008
4	Hormones (Hormone)IBA 03/2016 - 09/2003
3	Phosphotransferases (Kinase)IBA 01/2021 - 08/2014
3	Pharmaceutical PreparationsIBA 01/2017 - 10/2007
3	LeptinIBA 01/2017 - 04/2010
3	LipidsIBA 01/2016 - 01/2011
3	LigandsIBA 11/2015 - 08/2003
3	Cadherins (E-Cadherin)IBA 06/2012 - 08/2002
3	Cisplatin (Platino)FDA LinkGeneric 03/2010 - 01/2004
3	DNA (Deoxyribonucleic Acid)IBA 06/2009 - 01/2005
3	interleukin-20 receptorIBA 02/2007 - 12/2004
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2017
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 02/2011
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2017 - 01/2014
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017 - 08/2014
2	DNA AdductsIBA 01/2016 - 10/2013
2	AntioxidantsIBA 01/2016 - 10/2013
2	Reactive Nitrogen SpeciesIBA 01/2016 - 10/2013
2	3-nitrotyrosineIBA 08/2014 - 09/2008
2	ParaffinIBA 08/2014 - 01/2004
2	Transcription Factors (Transcription Factor)IBA 06/2012 - 01/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2010 - 08/2004
2	NF-kappa B (NF-kB)IBA 01/2009 - 06/2004
2	Biomarkers (Surrogate Marker)IBA 04/2007 - 12/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2006 - 10/2002
2	beta CateninIBA 05/2005 - 08/2003
2	RNA (Ribonucleic Acid)IBA 01/2005 - 08/2004
1	Long Noncoding RNAIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2021
1	Prostaglandin-E SynthasesIBA 01/2019
1	Arginine (L-Arginine)FDA Link 01/2018
1	CitrullineIBA 01/2018
1	OrnithineIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2017
1	AntigensIBA 01/2017
1	Insulin-Like PeptidesIBA 01/2017
1	Oncogene Proteins (Oncogene Protein)IBA 01/2017
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2017
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2017
1	VemurafenibIBA 10/2016
1	4- (benzo(b)thiophen- 2- yl)- 3- bromo- 5- hydroxydihydrofuran- 2(3H)- oneIBA 05/2016
1	Dinoprostone (PGE2)FDA Link 05/2016
1	MutagensIBA 04/2016
1	CarcinogensIBA 04/2016
1	4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA 04/2016
1	AM0010IBA 01/2015
1	Formaldehyde (Formol)FDA Link 08/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2014
1	trans-sodium crocetinate (crocetin)IBA 02/2014
1	GTP Phosphohydrolases (GTPases)IBA 02/2014
1	Small Interfering RNA (siRNA)IBA 02/2014
1	ElementsIBA 01/2014
1	Oxidants (Oxidizing Agents)IBA 10/2013
1	Type 1 Melanocortin ReceptorIBA 05/2013
1	bardoxolone methylIBA 01/2013
1	ChemokinesIBA 08/2012
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 03/2012
1	Interleukin-2 (IL2)IBA 02/2012
1	ChloridesIBA 01/2012
1	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 01/2012
1	PlatinumIBA 01/2012
1	CholesterolIBA 01/2012
1	Neutralizing AntibodiesIBA 11/2011

Therapy/Procedure

25	Therapeutics 01/2022 - 02/2002
7	Immunotherapy 01/2019 - 03/2009
5	Drug Therapy (Chemotherapy) 10/2019 - 12/2008
1	Precision Medicine 01/2017
1	Biological Therapy 02/2012